New Investor Libertatis Ergo Holding joins the financing round alongside existing investors FIRST Fund, KIKK Capital and Oost NLfunding to further progress its pipeline of cardiovascular disease targets, taking its total seed financing to €3.8 millionOver €2 million in non-dilutive grant funding from EIC (European Innovation Council) to enable the further advancement of its technology...Read More

We are pleased to announce that we have been granted €1.45 million from the EIC-Transition to bring our hiPSC-3D cardiac strips into a high throughput setting. In this project, we will miniaturize,  automate and scale-up the production of human 3D cardiac strips by combining 3D cardiac tissues derived from human induced pluripotent stem cell (hiPSC)...Read More